Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

Abstract

Background: Local clinical practice dictated the need for a 3-4 hour turn-around time for sirolimus (SRL) analysis. Of the many reported methods using LC-MS/MS, most proved unsuitable because they involved time consuming sold-phase extraction (SPE) or markedly over-estimated SRL in patient samples (by 1.5 to 2-fold) and spiked quality assurance samples (by 15-20%), showed poor (>15%) interassay precision or low sensitivity when evaluated in-house.
Material/Methods: Using stepwise optimisation of the pre-treatment, chromatography and tandem-mass spectrometry stages of the method we were able to successfully validate a method to FDA standards. Pretreatment with methanolic NH[sub]4[/sub] CO[sub]3[/sub]/ZnSO[sub]4[/sub] improved precipitation and optimised sirolimus extraction. Chromatography was enhanced using a C8 column and a column purge with 100% methanol reduced apparent ion-enhancement. Mass spectrometry with a low desolvation temperature removed a co-eluting peak.
Results: We identified a lower limit of quantification of 1.5 μg/L, inter-assay precision <12% from 2.9 to 40.0 μg/L and linearity to at least 50 μg/L. Recovery of spiked samples gave a median recovery of 107% and analysis of 27 stored quality assurance samples (patient pools and spiked samples) a median z value of +0.3 compared to the LC-MS/MS group mean. Comparison of results in 186 samples from liver, renal, pancreatic islet and bone marrow transplant recipients showed good agreement with a reference laboratory using LC-MS/MS and SPE: median (interquartile range) bias of +4.30% (-0.10 to 9.03%).
Conclusions: Timely analysis of SRL in patient samples is possible with satisfactory sensitivity and precision using LC-MS/MS without prior SPE.

Keywords: Sirolimus, Chromatography, analysis

0 Comments

In Press

04 Aug 2022 : Original article  

Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...

Ann Transplant In Press; DOI: 10.12659/AOT.936888  

22 Jul 2022 : Original article  

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...

Ann Transplant In Press; DOI: 10.12659/AOT.936937  

22 Jul 2022 : Original article  

Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...

Ann Transplant In Press; DOI: 10.12659/AOT.936732  

22 Jul 2022 : Original article  

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.936751  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358